QA: Aurinia Pharmaceuticals Inc in us_pharma/2025

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001600620_2026_Aurinia_Pharmaceuticals_Inc.pdf

Logs

Graph

Absolute values for 0001600620, Aurinia Pharmaceuticals Inc

  xvar xval
0 AssetsCurrent 491,967,000
1 IntangibleAssetsNetIncludingGoodwill 3,761,000
2 PropertyPlantAndEquipmentNet 2,111,000
3 remainder_Assets 253,748,000
4 LiabilitiesCurrent 93,724,000
5 LiabilitiesNoncurrent 17,548,000
6 remainder_Liabilities 58,984,000
7 CostOfGoodsAndServicesSold 43,469,365
8 SellingGeneralAndAdministrativeExpense -20,973,535
9 ResearchAndDevelopmentExpense 31,103,690
10 remainder_Expenses 24,572,010
11 remainder_Revenues 335,932,982
12 remainder_NetIncome 12,176,992
13 remainder_ComprehensiveNetIncome 60,785
  yvar yval
0 Assets 751,587,000
1 Liabilities 170,256,000
2 Expenses 78,171,530
3 Revenues 335,932,982
4 StockholdersEquity 581,331,000
5 NetIncome 269,938,444
6 ComprehensiveNetIncome 269,968,836
7 BaseVar 674,092,644
8 EconomicCapitalRatiobeforeLimitedLiability 3.34
9 EconomicCapitalRatio 3.91

Edgar->Model Mapping

Feature Distribution

Change over Time